Patients and method: Uncontrolled clinical interventional study including 38 patients with stage IB-IIIA non-squamous NCSLC who had radical surgery at the K hospital and received 4 cycles of pemetrexed-carboplatin adjuvant treatment between January 2020 and May 2022.